Sign inJoin waitlistJoin the waitlist

DH

Daniel Haber

Director, Krantz Family Center for Cancer Research · Mass General Brigham

Credentials: · · ·

History

Krantz Family Center for Cancer Research · Mass General Brigham
Present

Medical Oncology
Internal Medicine

Research

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
New England Journal of Medicine · 2004 · Last of 14 authors · 9,364 citations
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development
Cell · 1999 · 4,615 citations
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
New England Journal of Medicine · 2010 · 3,649 citations

David Ting
42 papers · 4 as a fellow
Lecia Sequist
41 papers · 4 as a fellow
SR
Sridhar Ramaswamy
30 papers
David Miyamoto
24 papers · 3 as a resident
Anthony Iafrate
23 papers
DS
Dennis Sgroi
23 papers
Aditya Bardia
22 papers
MR
Miguel Rivera
20 papers · 6 as a resident
LE
Leif Ellisen
19 papers · 5 as a fellow
Thomas Lynch
16 papers
DM
Douglas Micalizzi
15 papers · 7 as a resident
KI
Kurt Isselbacher
15 papers

Grants

Training Program in Cancer Biology and Therapeutics
National Cancer Institute · T32
Contact PI · $4.1M · Massachusetts General Hospital
1997–2028
Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor Cells
National Cancer Institute · R01
Contact PI · $7.5M · Massachusetts General Hospital
2008–2028
Microfluidic Sorting of Lung Cancer Cells from Leukapheresis Product as an Alternative to Metastatic Tumor Biopsy
National Cancer Institute · R01
PI · $2.2M · Massachusetts General Hospital
2021–2026
High-Flow Microfluidics of Leukapheresis Blood Products for Functional Analysis of Breast Circulating Tumor Cells
National Cancer Institute · R01
PI · $3.2M · Massachusetts General Hospital
2021–2025